Literature DB >> 3936867

Effect of mucolytic and bronchodilator aerosol therapy on airway resistance in mechanically ventilated patients.

D F Zandstra, C P Stoutenbeek, D R Miranda.   

Abstract

Nebulisation of a 10% solution of Mesna (Mistabron) in 10 postoperatively ventilated patients without preexisting pulmonary disease caused a significant increase in inspiratory resistance. This increase is effectively blocked by addition of a bronchodilator (i.e. Salbutamol) to the aerosol. No significant changes in airway resistance were observed in the 10 patients receiving salbutamol alone or isotonic saline. The expiratory resistance did not change suggesting that only the larger airways are involved in the constrictive effect of the drug. Although no patient showed clinical signs of bronchospasm, it is worth considering that even in patients without history of obstructive pulmonary disease nebulisation of Mesna should be performed in combination with a bronchodilator.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3936867     DOI: 10.1007/bf00273544

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  17 in total

1.  Effect of salbutamol on respiratory function in children with asthma.

Authors:  B H Bass; M E Disney; J Morrison-Smith
Journal:  Lancet       Date:  1969-08-23       Impact factor: 79.321

2.  Dynamic and static lung volumes and blood-gas tensions in bronchial asthma.

Authors:  K N Palmer; M L Diament
Journal:  Lancet       Date:  1969-03-22       Impact factor: 79.321

3.  Salbutamol and isoproterenol. A double-blind trial to compare bronchodilator and cardiovascular activity.

Authors:  A E Tattersfield; M W McNicol
Journal:  N Engl J Med       Date:  1969-12-11       Impact factor: 91.245

4.  Nebulization of N-acetylcysteine combined with a bronchodilator in patients with chronic bronchitis. A controlled study.

Authors:  R C Kory; S R Hirsch; J Giraldo
Journal:  Dis Chest       Date:  1968-12

5.  Human pharmacological and clinical studies on salbutamol: a specific beta-adrenergic bronchodilator.

Authors:  M C Kennedy; W T Simpson
Journal:  Br J Dis Chest       Date:  1969-07

6.  Bronchodilator aerosols.

Authors:  T T Chapman
Journal:  Br Med J       Date:  1969-11-29

7.  Mechanisms of airway response to inhaled substances.

Authors:  J A Nadel
Journal:  Arch Environ Health       Date:  1968-02

8.  Acute effects of nebulization of N-acetylcysteine on pulmonary mechanics and gas exchange.

Authors:  S Rao; D B Wilson; R C Brooks; B J Sproule
Journal:  Am Rev Respir Dis       Date:  1970-07

9.  A controlled study of the safety and efficacy of acetylcysteine-isoproterenol combination.

Authors:  D F Pulle; P Glass; M J Dulfano
Journal:  Curr Ther Res Clin Exp       Date:  1970-08

10.  Clinical and physiological evaluation of mucolytic agents nebulized with soproterenol: 10 per cent N-acetylcysteine verus 10 per cent 2-mercaptoethane sulphonate.

Authors:  S R Hirsch; P F Viernes; R C Kory
Journal:  Thorax       Date:  1970-11       Impact factor: 9.139

View more
  2 in total

1.  Precision medicine and aerosolization in mechanically ventilated adults.

Authors:  Jordi Rello; Christian Domingo
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

2.  Preventive nebulization of mucolytic agents and bronchodilating drugs in invasively ventilated intensive care unit patients (NEBULAE): study protocol for a randomized controlled trial.

Authors:  Sophia M van der Hoeven; Jan M Binnekade; Corianne A J M de Borgie; Frank H Bosch; Henrik Endeman; Janneke Horn; Nicole P Juffermans; Nardo J M van der Meer; Maruschka P Merkus; Hazra S Moeniralam; Bart van Silfhout; Mathilde Slabbekoorn; Willemke Stilma; Jan Willem Wijnhoven; Marcus J Schultz; Frederique Paulus
Journal:  Trials       Date:  2015-09-02       Impact factor: 2.279

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.